Patient demographics and clinical characteristic
| . | n (%) . |
|---|---|
| Age, y | |
| Median | 42 |
| Range | 18-84 |
| Sex | |
| Male | 50 (59) |
| Female | 35 (41) |
| Race | |
| African American | 3 (3.5) |
| Asian | 7 (8.2) |
| Hispanic | 30 (35) |
| White | 45 (53) |
| Sample collection | |
| Pre-InO only | 42 |
| Pre- and post-InO | 28 |
| Post-InO only | 15 |
| WBC count, ×109/L | |
| Median | 4.2 |
| Range | 0.1-107.3 |
| Salvage-treatment phase | |
| 0 | 4 (4.7) |
| 1 | 34 (40) |
| 2 | 25 (29) |
| 3 | 9 (11) |
| 4 | 8 (9.4) |
| 5 | 5 (5.9) |
| BM blast percentage, n (%) | |
| Median (range) | 66 (10-97) |
| >5% to ≤50% | 28 (33) |
| >50% | 53 (62) |
| Unknown | 4 (4.7) |
| . | n (%) . |
|---|---|
| Age, y | |
| Median | 42 |
| Range | 18-84 |
| Sex | |
| Male | 50 (59) |
| Female | 35 (41) |
| Race | |
| African American | 3 (3.5) |
| Asian | 7 (8.2) |
| Hispanic | 30 (35) |
| White | 45 (53) |
| Sample collection | |
| Pre-InO only | 42 |
| Pre- and post-InO | 28 |
| Post-InO only | 15 |
| WBC count, ×109/L | |
| Median | 4.2 |
| Range | 0.1-107.3 |
| Salvage-treatment phase | |
| 0 | 4 (4.7) |
| 1 | 34 (40) |
| 2 | 25 (29) |
| 3 | 9 (11) |
| 4 | 8 (9.4) |
| 5 | 5 (5.9) |
| BM blast percentage, n (%) | |
| Median (range) | 66 (10-97) |
| >5% to ≤50% | 28 (33) |
| >50% | 53 (62) |
| Unknown | 4 (4.7) |
Data are presented for 85 patients.
BM, bone marrow; WBC, white blood cell.